Studies conducted on models of arthritis, multiple sclerosis, and type 1 diabetes have also shown the ability of CBD to inhibit the JAK/STAT activator IFN-γ [73, 83–86]. This evidence concerns the gene SOAT1 and type 1 diabetes mellitus.